Table w1Members of the Community Musculoskeletal Research Group
Table w1 Outcome at four weeks and six and 12 months for patients with lateral epicondylitis according to treatment group. Values are numbers (percentages) of patients*
| 4 weeks | | 6 months | | 12 months |
| Injection (n=53) | Naproxen (n=53) | Placebo (n=58) | | Injection (n=53) | Naproxen (n=53) | Placebo (n=58) | | Injection (n=53) | Naproxen (n=53) | Placebo (n=58) |
Pain | | | | | | | | | | | |
Elbow pain today | 27 (51) | 47 (89) | 51 (88) | | 36 (68) | 21 (40) | 26 (45) | | 24 (45) | 18 (34) | 20 (35) |
Pain every day for 1 week | 22 (42) | 38 (72) | 43 (74) | | 28 (53) | 16 (30) | 19 (33) | | 17 (32) | 12 (23) | 12 (21) |
Pain for at least 1 day in past week | 30 (57) | 50 (94) | 55 (95) | | 46 (87) | 29 (55) | 37 (64) | | 37 (70) | 25 (47) | 27 (47) |
Movement and strength | | | | | | | | | | | |
Grip strength >300 mm Hg | 20 (38) | 4 (8) | 8 (14) | | 14 (26) | 13 (25) | 18 (31) | | 17 (32) | 24 (45) | 23 (40) |
Pain on extension of middle finger | 26 (49) | 48 (91) | 45 (78) | | 38 (72) | 27 (51) | 32 (55) | | 25 (47) | 24 (45) | 21 (37) |
Pain on extension of wrist | 19 (36) | 45 (85) | 47 (81) | | 39 (74) | 25 (47) | 32 (55) | | 29 (55) | 20 (38) | 20 (35) |
Tenderness | 31 (59) | 49 (93) | 53 (91) | | 42 (79) | 32 (60) | 36 (62) | | 35 (66) | 25 (47) | 34 (60) |
Disability | | | | | | | | | | | |
Dressing | 11 (21) | 30 (57) | 28 (52) | | 16 (31) | 5 (10) | 10 (19) | | 13 (27) | 4 (8) | 9 (16) |
Feeding | 20 (38) | 34 (65) | 35 (64) | | 28 (55) | 18 (35) | 19 (34) | | 17 (34) | 12 (23) | 13 (23) |
Washing | 20 (38) | 33 (64) | 39 (71) | | 24 (46) | 15 (29) | 22 (41) | | 19 (37) | 12 (24) | 13 (24) |
Household tasks | 23 (44) | 43 (83) | 46 (81) | | 35 (66) | 25 (48) | 26 (47) | | 29 (57) | 19 (36) | 24 (43) |
Opening doors | 12 (24) | 23 (45) | 23 (47) | | 15 (29) | 4 (8) | 7 (14) | | 9 (18) | 1 (2)¶ | 9 (17) |
Carrying objects | 24 (47) | 47 (89) | 49 (86) | | 38 (72) | 22 (42) | 34 (61) | | 32 (63) | 24 (45) | 30 (53) |
With work | 19 (36) | 35 (73) | 38 (72) | | 28 (55) | 19 (40) | 24 (44) | | 23 (46) | 14 (29) | 18 (33) |
With sport | 20 (39) | 31 (74) | 33 (67) | | 23 (46) | 18 (40) | 19 (38) | | 18 (38) | 14 (33) | 15 (28) |
*Percentages may not calculate exactly because of missing data.
P<0.05 for injection versus naproxen.
P <0.05 for injection versus placebo.
¶P <0.05 for naproxen versus placebo.
Members of the Community Musculoskeletal Research Group were
Drs T Baker, J Barber, A Bartlam, S Bradbury, M Brown, G Carpenter, R Chambers, V Cooper, G Davenport, A Dent, J Dixon, H Dobson, S Fawcett, M Fisher, P Franklin, J Gray, K Haill, P Hamilton, B Hufton, A Irvine, G Kay, S Manian, G Morgans, R Muirhead, C Oleshko, J Oxtoby, N Patel, M Porcheret, R Potter, D Price, A Pritchard, A Ralphs, P Rigby, T Schur, P Scott, K Seth, M Shapley, S Somerville, P Turner, A Vaghmaria, and J Worthington.
Rapid Responses:
Read all Rapid Responses
- question
- Hesam Joghtaee
- bmj.com, 11 Aug 2001 [Full text]